Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, MODELOS ANIMAIS, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Fernanda F. et al. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy. Frontiers in Pharmacology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fphar.2016.00303. Acesso em: 14 out. 2024.APA
Peres, F. F., Levin, R., Almeida, V., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. de S., & Abilio, V. C. (2016). Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy. Frontiers in Pharmacology, 7. doi:10.3389/fphar.2016.00303NLM
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 out. 14 ] Available from: https://doi.org/10.3389/fphar.2016.00303Vancouver
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 out. 14 ] Available from: https://doi.org/10.3389/fphar.2016.00303